SEPT2 and SEPT11 are upregulated in renal cell carcinoma (RCC), an aggressive and highly metastatic cancer of the kidney with poor response to therapeutics (Craven et al., 2006; Craven, Stanley, et al., 2006). The gene discussed is SEPTIN6; the disease is renal cell carcinoma.